drugset / Trial / NCT03660943

A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain

NCT03660943

Phase 3 Completed 332 enrolled Centrexion Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled, 2-injection, 52-week study to evaluate the efficacy and safety of intra-articular injections of CNTX-4975-05 in subjects with chronic, moderate-to-severe osteoarthritis knee pain.

Timeline

Start
2018-09-09
Primary completion
2020-06-11
Completion
2020-06-11

Drugs

EvaluationDrugModalityDoseRoute
Subject CNTX-4975-05 Unknown 2 ml Other

Indications